Urethra Neoplasm — Trials

Urethra Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

85 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01352962	Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid Tumors	completed	Phase 1	18	National Cancer Institute (NCI)NIH	1	Sep 16, 2026	clinicaltrials
NCT02437370	Pembrolizumab and Docetaxel or Gemcitabine Hydrochloride in Treating Patients Urothelial Cancer	completed	Phase 1	32	University of California, DavisOTHER	1	Oct 18, 2022	clinicaltrials
NCT01090466	Gemcitabine Hydrochloride, Cisplatin, and Temsirolimus as First-Line Therapy in Treating Patients With Locally Advanced and/or Metastatic Transitional Cell Cancer of the Urothelium	completed	Phase 1 / Phase 2	15	Cardiff UniversityOTHER	1	Feb 6, 2018	clinicaltrials
NCT00082719

Data updated 13 days agoSource updated Sep 16, 2026source: clinicaltrials